Literature DB >> 17350421

Delayed diagnosis of cerebellar hemangioblastoma after intracerebellar hemorrhage.

Jong-Young Lee1, Byung-Moon Cho, Sae-Moon Oh, Se-Hyuck Park.   

Abstract

BACKGROUND: Cerebellar hemorrhage caused by cerebellar hemangioblastoma is not a frequent case. We report a case of solid, cerebellar hemangioblastoma, diagnosed 4 years after cerebellar hemorrhage. CASE DESCRIPTION: A 69-year-old man presented with dizziness and gait disturbance. He had a 4-year history of evacuation of cerebellar hemorrhage. Gadolinium-enhanced MRI revealed a well-enhancing mass in the left cerebellar hemisphere, and vertebral angiography revealed hypervascularity. Radiotherapy was given to the tumor bed. He remained stable for more than a year after radiation.
CONCLUSION: In cases of spontaneous cerebellar hemorrhage, particularly in the patient without hypertension or other underlying diseases related to bleeding from tumor, cerebellar hemangioblastoma should be suspected as a rare cause of hemorrhage, and computed tomography and/or MRI with contrast administration is mandatory for differential diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 17350421     DOI: 10.1016/j.surneu.2006.06.021

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

Review 1.  Massive hemorrhage in hemangioblastomas Literature review.

Authors:  Javier Ros de San Pedro; Fernando Alarcón Rodríguez; Belén Ferri Níguez; Juan F Martínez-Lage Sánchez; Antonio López López-Guerrero; Matías Felipe Murcia; Antonio M Ruíz-Espejo Vilar
Journal:  Neurosurg Rev       Date:  2010-01       Impact factor: 3.042

2.  Surgical resection of cerebellar hemangioblastoma with enhanced wall thickness: A report of two cases.

Authors:  Zhenxing Sun; Dan Yuan; Yaxing Sun; Pengxiang Yan; Huancong Zuo
Journal:  Oncol Lett       Date:  2015-02-10       Impact factor: 2.967

Review 3.  Intratumoral hemorrhage in a patient with cerebellar hemangioblastoma: a case report and review.

Authors:  Zhen Wang; Jun Hu; Liang Xu; Jay Malaguit; Sheng Chen
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.